Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 6 | 108564420 | intron variant | C/T | snv | 0.30 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
1.000 | 0.040 | 6 | 108677702 | intron variant | G/A;C;T | snv |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.851 | 0.160 | 6 | 108587315 | intron variant | G/T | snv | 0.50 |
|
Mental Disorders | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||||
|
0.851 | 0.160 | 6 | 108587315 | intron variant | G/T | snv | 0.50 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.851 | 0.160 | 6 | 108587315 | intron variant | G/T | snv | 0.50 |
|
Pathological Conditions, Signs and Symptoms; Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.851 | 0.160 | 6 | 108587315 | intron variant | G/T | snv | 0.50 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.790 | 0.160 | 6 | 108682118 | 3 prime UTR variant | T/A;C | snv |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.790 | 0.160 | 6 | 108682118 | 3 prime UTR variant | T/A;C | snv |
|
Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.790 | 0.160 | 6 | 108682118 | 3 prime UTR variant | T/A;C | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Digestive System Diseases | 0.030 | 0.667 | 3 | 2013 | 2015 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Infections | 0.020 | 0.500 | 2 | 2013 | 2015 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Pathological Conditions, Signs and Symptoms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Infections | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
1.000 | 0.040 | 6 | 108675760 | intron variant | G/T | snv | 0.54 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | ||||||||
|
1.000 | 6 | 108656460 | 5 prime UTR variant | T/C | snv | 0.55 |
|
0.700 | 1.000 | 1 | 2015 | 2015 | |||||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Infections | 0.020 | 1.000 | 2 | 2015 | 2016 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.020 | 0.500 | 2 | 2013 | 2016 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Infections | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Infections | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Infections | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Infections | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Infections | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.716 | 0.320 | 6 | 108659993 | intron variant | T/G | snv | 0.14 |
|
Infections; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 |